Revance Therapeutics
Revance Therapeutics
World Rank (Jan-05-2024)
9,978
Market Cap (Jan-05-2024)
0.772 Billion USD
World Rank (Jul-30-2023)
5,937
Market Cap (Jul-30-2023)
1.893 Billion USD
World Rank (Jan-07-2022)
8,614
Market Cap (Jan-07-2022)
1.166 Billion USD
World Rank (Jan-01-2021)
5,660
Market Cap (Jan-01-2021)
1.886 Billion USD
Headquarters Country
Nasdaq / NYSE Code
RVNC
Employee Count
495
Employee Count as of Date
As on 2021
Headquarters City/State
World Region
World Subregion
Annual Revenue in USD
132 Million USD
Annual Net Income in USD
-356 Million USD
Annual Results for Period Ending
Dec-2022 ending year
Total Assets in USD
581 Million USD
Total Liabilities in USD
569 Million USD
Total Equity in USD
13 Million USD
Balance Sheet for Period Ending
Dec-2022 ending year
Business Sector
Company Website
Yahoo
Ads